Why Novavax Stock Slipped on Thursday
The departing party is Greg Glenn, the president of research and development. First, research and development is a crucial area for biotechs like Novavax, as their future is heavily dependent on their pipeline programs. Second, Glenn was a longtime company mainstay, having joined Novavax in 2010.